人类P53下游基因一致性序列研究

人类P53蛋白是一种通用转录因子，通过调控一系列下游基因的转录来影响许多细胞功能。p53下游基因含有P53蛋白结合序列，收集已报道的63条人类P53蛋白结合序列并与E1-Deiry等定义的一致性序列进行比较，发现这些P53蛋白结合序列与一致性序列特征并不严格一致，对这些偏差规律的分析有利于建立p53下游基因预测模型，进而利用计算机方法预测p53下游基因，研究其基因互作网络。     

人类P53下游基因一致性序列研究

人类P53蛋白是一种通用转录因子,通过调控一系列下游基因的转录来影响许多细胞功能。p53下游基因含有P53蛋白结合序列,收集已报道的63条人类P53蛋白结合序列并与ElDeiry等定义的一致性序列进行比较,发现这些P53蛋白结合序列与一致性序列特征并不严格一致,对这些偏差规律的分析有利于建立p53下游基因预测模型,进而利用计算机方法预测p53下游基因,研究其基因互作网络。     

用AFM观察小白鼠心肌核DNA片段的基因体外转录和垃圾DNA的相互作用

用AFM直接观察、体外转录等实验技术组合,发现小白鼠(Balb/C)心肌体外转录状态的核DNA片段上的各种基因,处于垃圾DNA的特定的“转录平台”上。“转录平台”上的各种核活性基因的两端的调控序列,分别与特定开关蛋白质复合体结合(即可解离的开关蛋白质),中间的编码序列分别以非共价键特异结合可完全解离的转录活性因子等多种蛋白质;这些与核基因转录相关的蛋白质均由垃圾DNA的专一性蛋白质通路分别进行特异性正负反馈调控。     

A new type of synthetic peptide library for identifying ligand-binding activity

Our aim was to improve techniques for drug development by facilitating the identification of small molecules that bind with high affinity to acceptor molecules (for example, cell-surface receptors, enzymes, antibodies) and so to mimic or block their interaction with the natural ligand. Previously such small molecules have been characterized individually on a serial basis. The systematic synthesis and screening of peptide libraries of defined structure represents a new approach. For relatively small libraries, predetermined sequence variations on solid-phase supports have been used, and large libraries have been produced using a bacteriophage vector into which random oligodeoxynucleotide sequences have been introduced, but these techniques have severe limitations. Here we investigate an alternative approach to synthesis and screening of peptide libraries. Our simple methodology greatly enhances the production and rapid evaluation of random libraries of millions of peptides so that acceptor-binding ligands of high affinity can be rapidly identified and sequenced, on the basis of a 'one-bead, one-peptide' approach.     

一种新的MDM2-p53信号通路抑制剂的发现研究

本研究以研发新型小分子MDM2抑制剂为目的,建立了以分子对接为基础的虚拟筛选流程.利用虚拟筛选流程对SPECS化合物库的分子进行类药性筛选、分子对接粗筛、二次筛选以及排序挑选,并通过细胞实验验证这些分子激活p53并抑制肿瘤细胞生长的活性.结果表明M12能够激活p53及其下游信号通路,抑制肿瘤细胞周期并促进肿瘤细胞凋亡.M12与已知MDM2-p53抑制剂结构完全不同,是一种潜在的癌症治疗候选药物.     

Navigating chemical space for biology and medicine

Despite over a century of applying organic synthesis to the search for drugs, we are still far from even a cursory examination of the vast number of possible small molecules that could be created. Indeed, a thorough examination of all 'chemical space' is practically impossible. Given this, what are the best strategies for identifying small molecules that modulate biological targets? And how might such strategies differ, depending on whether the primary goal is to understand biological systems or to develop potential drugs?